Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
PodcastThe Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

June 26, 2026
Vol.52 No.25
By Paul Goldberg and Claire Marie Porter
In Brief

NCI renews the UC San Diego Moores CCSG, committing $25M

June 18, 2026
Vol.52 No.24
House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget
Capitol Hill

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

June 12, 2026
Vol.52 No.23
By Paul Goldberg
As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

June 12, 2026
Vol.52 No.23
By Paul Goldberg
In Brief

NCI selects UChicago Medicine as a lead site for clinical trials

June 12, 2026
Vol.52 No.23
As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
Podcast

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

May 27, 2026
NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing
Capitol HillNCI

NCI’s Letai gets softball questions from Senate appropriators at an otherwise contentious hearing

May 22, 2026
Vol.52 No.20
By Jacquelyn Cobb
USPSTF leaders John Wong and Esa Davis fired by Kennedy, leaving the panel rudderless
Capitol Hill

USPSTF leaders John Wong and Esa Davis fired by Kennedy, leaving the panel rudderless

May 22, 2026
Vol.52 No.20
By Claire Marie Porter
At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
NCI

At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylines
There’s “clear evidence that funding is moving and the system is working.”

April 24, 2026
Vol.52 No.16
By Sara Willa Ernst
Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
In Brief

Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years

April 17, 2026
Vol.52 No.15

Posts navigation

12…39Next

Trending Stories

  • Joe Fraumeni, founder of molecular epidemiology, dies at 93
    “It’s hard to imagine a world without the presence of this gentle scientific giant.”
  • The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
    “Institutions are feeling crunched in so many different directions”
  • Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
  • Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital
  • To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements
  • FDA advisory panel recommends first-of-its-kind mRNA flu vaccine for older adults

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account